• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Erosive oral lichen planus successfully treated with JAK3/TEC inhibitor ritlecitinib: A case report.

作者信息

Katz Abigail, Lambert Raphaella, Ahmed Areeba, Patel Deep, Soto-Canetti Gabriela, Talia Jordan, Adalsteinsson Jonas A

机构信息

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.

Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

JAAD Case Rep. 2025 Jun 16;63:70-72. doi: 10.1016/j.jdcr.2025.05.017. eCollection 2025 Sep.

DOI:10.1016/j.jdcr.2025.05.017
PMID:40787044
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12329467/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/f6b6137693a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/99c38db671ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/82ffc096cbf8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/f6b6137693a4/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/99c38db671ad/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/82ffc096cbf8/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5e4/12329467/f6b6137693a4/gr3.jpg

相似文献

1
Erosive oral lichen planus successfully treated with JAK3/TEC inhibitor ritlecitinib: A case report.JAK3/TEC抑制剂芦可替尼成功治疗糜烂性口腔扁平苔藓：一例报告
JAAD Case Rep. 2025 Jun 16;63:70-72. doi: 10.1016/j.jdcr.2025.05.017. eCollection 2025 Sep.
2
Target Occupancy and Functional Inhibition of JAK3 and TEC Family Kinases by Ritlecitinib in Healthy Adults: An Open-Label, Phase 1 Study.利特昔替尼在健康成年人中对 JAK3 和 TEC 家族激酶的靶标占有率和功能抑制作用：一项开放标签、I 期研究。
J Clin Pharmacol. 2024 Jan;64(1):67-79. doi: 10.1002/jcph.2347. Epub 2023 Sep 29.
3
Successful treatment of erosive lichen planus with Upadacitinib complicated by oral squamous cell carcinoma.乌帕替尼成功治疗糜烂性扁平苔藓并并发口腔鳞状细胞癌。
SAGE Open Med Case Rep. 2023 Nov 16;11:2050313X231213144. doi: 10.1177/2050313X231213144. eCollection 2023.
4
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalis.利特昔替尼（一种口服 JAK3/TEC 家族激酶抑制剂）治疗全秃和普秃青少年和成年患者的疗效和安全性。
J Dermatol. 2024 Nov;51(11):1414-1424. doi: 10.1111/1346-8138.17442. Epub 2024 Sep 27.
5
Interventions for erosive lichen planus affecting mucosal sites.针对累及黏膜部位的糜烂性扁平苔藓的干预措施。
Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD008092. doi: 10.1002/14651858.CD008092.pub2.
6
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligo.JAK3/TEC家族激酶抑制剂利特昔替尼对白癜风患者免疫/黑素细胞生物标志物的改善作用
J Allergy Clin Immunol. 2024 Jan;153(1):161-172.e8. doi: 10.1016/j.jaci.2023.09.021. Epub 2023 Sep 28.
7
Bullous Lichen Planus: Case Report and Review.大疱性扁平苔藓：病例报告与综述
J Pharm Bioallied Sci. 2019 May;11(Suppl 2):S499-S506. doi: 10.4103/JPBS.JPBS_58_19.
8
[Photopheresis: an alternative therapeutic approach in corticoresistant erosive oral lichen planus].[光化学疗法：皮质激素抵抗性糜烂性口腔扁平苔藓的一种替代治疗方法]
Ann Dermatol Venereol. 2008 Mar;135(3):209-12. doi: 10.1016/j.annder.2007.06.010. Epub 2008 Mar 4.
9
Effective treatment of refractory lichen planus pemphigoides with a Janus kinase-1/2 inhibitor.Janus 激酶-1/2 抑制剂治疗难治性类天疱疮样扁平苔藓有效。
Clin Exp Dermatol. 2022 Nov;47(11):2040-2041. doi: 10.1111/ced.15344. Epub 2022 Aug 18.
10
Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo.利特昔替尼，一种 JAK3/TEC 家族激酶抑制剂，可稳定活跃病变并重新色素化稳定病变中的白癜风。
Arch Dermatol Res. 2024 Jul 18;316(7):478. doi: 10.1007/s00403-024-03182-y.

本文引用的文献

1
Translational Research in Oral Lichen Planus: From Laboratory Discoveries to Clinical Applications.口腔扁平苔藓的转化研究：从实验室发现到临床应用
Cureus. 2024 Oct 14;16(10):e71462. doi: 10.7759/cureus.71462. eCollection 2024 Oct.
2
What can we learn from treatments of oral lichen planus?我们能从口腔扁平苔藓的治疗中学到什么？
Front Cell Infect Microbiol. 2024 Feb 15;14:1279220. doi: 10.3389/fcimb.2024.1279220. eCollection 2024.
3
Direct immunofluorescence cannot be used solely to differentiate among oral lichen planus, oral lichenoid lesion, and oral epithelial dysplasia.
直接免疫荧光不能单独用于区分口腔扁平苔藓、口腔苔藓样病变和口腔上皮发育异常。
J Dent Sci. 2023 Oct;18(4):1669-1676. doi: 10.1016/j.jds.2023.01.025. Epub 2023 Feb 8.
4
Oral Lichen Planus: An Update on Diagnosis and Management.口腔扁平苔藓：诊断与管理的最新进展
Am J Clin Dermatol. 2024 Jan;25(1):35-53. doi: 10.1007/s40257-023-00814-3. Epub 2023 Sep 15.
5
The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review.Janus 激酶抑制剂在扁平苔藓中的应用：基于证据的综述。
J Cutan Med Surg. 2023 May-Jun;27(3):271-276. doi: 10.1177/12034754231156100. Epub 2023 Feb 23.
6
Expression of the Selected Proteins of JAK/STAT Signaling Pathway in Diseases with Oral Mucosa Involvement.JAK/STAT 信号通路相关蛋白在口腔黏膜疾病中的表达。
Int J Mol Sci. 2022 Dec 24;24(1):323. doi: 10.3390/ijms24010323.
7
JAK inhibitors in lichen planus: a review of pathogenesis and treatments.JAK 抑制剂在扁平苔藓中的应用：发病机制和治疗方法的综述。
J Dermatolog Treat. 2022 Dec;33(8):3098-3103. doi: 10.1080/09546634.2022.2116926. Epub 2022 Aug 29.
8
Diagnosis of oral lichen planus: a position paper of the American Academy of Oral and Maxillofacial Pathology.口腔扁平苔藓的诊断：美国口腔颌面病理学会立场文件
Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Sep;122(3):332-54. doi: 10.1016/j.oooo.2016.05.004. Epub 2016 Jul 9.